Clinical impact of Resistell's AST on treatment decisions in bacteremia and sepsis and method validation for new indications - Texts

Home
Main Navigation
Content
Search
Help

Font Standard Bold
Login

Research unit

INNOSUISSE

Project number

36334.1 IP-LS

Project title

Clinical impact of Resistell's AST on treatment decisions in bacteremia and sepsis and method validation for new indications

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-	-

Inserted texts

Category	Text
Short description (German)	Clinical impact of Resistell's AST on treatment decisions in bacteremia and sepsis and method validation for new indications
Short description (English)	Clinical impact of Resistell's AST on treatment decisions in bacteremia and sepsis and method validation for new indications
Abstract (German)	The goal of this project is the assessment of the impact of the new rapid phenotypic antibiotic susceptibility test developed by Resistell on clinical decision making in bacteremia and sepsis. In addition, the method will be validated for two new indications, tuberculosis and chlamydia infections.